Ethyl caffeate Inhibitor

1. Ethyl caffeate has anti-inflammatory activity. 2. Ethyl caffeate may as a promising natural compound for future application in chronic liver disease. 3. Ethyl caffeate is a potent chemopreventive compound against skin carcinogenesis caused by solar UV exposure. 4. Ethyl caffeate is the high-resolution structures of representative inhibitors in complex with human pancreatic alpha-amylase. 5. Ethyl caffeate strongly inhibits neoplastic transformation of JB6 Cl41 cells without toxicity. PI3K, ERK1/2, and p38 kinase activities were suppressed by direct binding with HOEC in vitro.

Small volumes of Ethyl caffeate, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5750290 is an inhibitor targeting Ethyl caffeate.